BD SurePath™ liquid-based Pap test
BD SurePath™ liquid-based Pap test is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses*. BD SurePath™ liquid-based Pap test provides the following advantages over conventional Pap smears and other LBC (Liquid-Based Collection) tests resulting in grea…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Very good to have one of these
Worth its weight in gold
It's awesome. Staff is friendly.
Review Date: 24 Sept 2021 | BD Biosciences
BD SurePath™ liquid-based Pap test is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses*.
BD SurePath™ liquid-based Pap test provides the following advantages over conventional Pap smears and other LBC (Liquid-Based Collection) tests resulting in greater disease detection.
BD SurePath™ test collection process allows the laboratory access for repeat testing from the residual cell solution, providing more effective patient management.
